These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37829142)

  • 1. Modulation of associations between education years and cortical volume in Alzheimer's disease vulnerable brain regions by Aβ deposition and
    Kim HB; Kim SH; Um YH; Wang SM; Kim REY; Choe YS; Lee J; Kim D; Lim HK; Lee CU; Kang DW
    Front Aging Neurosci; 2023; 15():1248531. PubMed ID: 37829142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
    Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
    J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of
    Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
    Front Aging Neurosci; 2022; 14():871323. PubMed ID: 35677201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients.
    Kang DW; Wang SM; Na HR; Lee CU; Baek IH; Lim HK
    Curr Alzheimer Res; 2020; 17(11):1023-1032. PubMed ID: 33372875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Education Years and Resting-state Functional Connectivity Modulated by
    Kim J; Kim S; Um YH; Wang SM; Kim RE; Choe YS; Lee J; Kim D; Lim HK; Lee CU; Kang DW
    Clin Psychopharmacol Neurosci; 2024 Feb; 22(1):169-181. PubMed ID: 38247423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals.
    Brugulat-Serrat A; Sánchez-Benavides G; Cacciaglia R; Salvadó G; Shekari M; Collij LE; Buckley C; van Berckel BNM; Perissinotti A; Niñerola-Baizán A; Milà-Alomà M; Vilor-Tejedor N; Operto G; Falcon C; Grau-Rivera O; Arenaza-Urquijo EM; Minguillón C; Fauria K; Molinuevo JL; Suárez-Calvet M; Gispert JD;
    EJNMMI Res; 2023 Mar; 13(1):18. PubMed ID: 36856866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
    Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
    Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.
    Adamczuk K; De Weer AS; Nelissen N; Chen K; Sleegers K; Bettens K; Van Broeckhoven C; Vandenbulcke M; Thiyyagura P; Dupont P; Van Laere K; Reiman EM; Vandenberghe R
    Neuroimage Clin; 2013; 2():512-20. PubMed ID: 24179803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
    Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
    Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
    Reiman EM; Chen K; Liu X; Bandy D; Yu M; Lee W; Ayutyanont N; Keppler J; Reeder SA; Langbaum JB; Alexander GE; Klunk WE; Mathis CA; Price JC; Aizenstein HJ; DeKosky ST; Caselli RJ
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6820-5. PubMed ID: 19346482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
    Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
    J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
    Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
    Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.